Zdrowie i gospodarka · 29/09/2015

FDA Releases Guidance on Generic Drug Development Correspondence

The Food and Drug Administration (FDA) has made available a guidance document for industry that outlines the process for submitting correspondence related to generic drug development and how the agency will communicate with industry regarding such requests.